INOFEA empowers enzymes. Enzyme stabilization and protection is INOFEA`s core business. We have developed an innovative and patented platform technology to provide enzymes with a protective shield. We unlock the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technology. This makes your enzymes 10 times more stable and they can be re-used easily. Our highly resistant enzymes support Biocatalysis including bioconjugation, diagnostics (bioanalysis) or can be formulated as active ingredients. Our technology addresses a wide range of biotech applications for the industry and demonstrated substantial benefits to customers in pharma, food processing, specialty chemicals and consumer care.
Looking for a particular INOFEA AG employee's phone or email?
The INOFEA AG annual revenue was $1 million in 2026.
Rita Correro is the CTO of INOFEA AG.
8 people are employed at INOFEA AG.
INOFEA AG is based in Basel, Basel-City.
The NAICS codes for INOFEA AG are [54, 54171, 541713, 541, 5417].
The SIC codes for INOFEA AG are [87, 873].